网红黑料

Skip to main content
(352) 733-0111

Tobacco cessation in cancer survivors and caregivers

  • Status
    Accepting Candidates
  • Age
    18 Years - N/A
  • Sexes
    All
  • 网红黑料y Volunteers
    Accepts 网红黑料y Volunteers
I'm interested
Share this study

Objective

Given the challenges to delivering tobacco cessation treatment in oncology care and the unique challenges faced by individuals attempting to quit tobacco after a cancer diagnosis, scalable cessation programs that are tailored to the experiences of cancer survivors that also integrate caregiver/family support are needed. To address this need,

This study will use an intervention that consists of two primary strategies: 1) a tailored cessation program for cancer survivors and family members/caregivers who use tobacco and 2) healthcare provider training.

网红黑料care providers will receive training on the AAC model (Ask patients about tobacco use, Advise patients to quit, Connect patients to cessation resources), including materials focused on tobacco cessation in cancer care from the CDC, as well as a brief evidence-based communication skills training based on the C-LEAR (Counsel, Listen, Empathize, Answer, Recommend) approach.

Details

Full study title Developing a scalable tobacco cessation program for cancer survivors and caregivers
Protocol number OCR46544
ClinicalTrials.gov ID NCT06851936
Phase N/A

Eligibility

Inclusion Criteria:

Cancer Survivors including Current Cancer Patients

  • Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month.

  • Any history of cancer diagnosis. Subjects currently receiving cancer-related treatments are eligible for enrollment.

  • Receiving care from the participating 网红黑料 clinics (Medical Oncology, Urology, and Radiation Oncology).

  • Capable of completing study requirements

  • Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes

  • Adults aged 鈮�18 years

Informal Caregivers/Family Members of Cancer Survivors

  • Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month.

  • A family member, informal caregiver, or friend of an enrolled cancer survivor receiving care from the participating 网红黑料 clinics as described above

  • Capable of completing study requirements

  • Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes

  • Adults aged 鈮�18 years

Exclusion Criteria:

Cancer Survivors including Current Cancer Patients

  • Patients unable to complete the sessions because of language, travel or technology barriers

  • Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.

Informal Caregivers/Family Members of Cancer Survivors

  • Participants unable to complete the sessions because of language, travel or technology barriers

  • Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.

Participate in a study

Here are some general steps to consider when participating in a research study:

  1. Step
    1

    Contact the research team

    Call or email the research team listed within the specific clinical trial or study to let them know that you're interested. A member of the research team, such as the researcher or study coordinator, will be available to tell you more about the study and to answer any questions or concerns you may have.

    Primary contact

  2. Step
    2

    Get screened to confirm eligibility

    You may be asked to take part in prescreening to make sure you are eligible for a study. The prescreening process ensures it is safe for you to participate. During the prescreening process, you will be asked some questions and you may also be asked to schedule tests or procedures to confirm your eligibility.

  3. Step
    3

    Provide your consent to participate

    If you are eligible and want to join the clinical trial or study, a member of the research team will ask for your consent to participate. To give consent, you will be asked to read and sign a consent form for the study. This consent form explains the study's purpose, procedures, risks, benefits and provides other important information, such as the study team's contact information.

  4. Step
    4

    Participate

    If you decide to participate in a clinical trial or study, the research team will keep you informed of the study requirements and what you will need to do to throughout the study. For some trials or studies, your health care provider may work with the research team to ensure there are no conflicts with other medications or treatments.